AC Immune SA Ret. on assets
What is the Ret. on assets of AC Immune SA?
The Ret. on assets of AC Immune SA is -31.89%
What is the definition of Ret. on assets?
Return on assets indicates how profitable a company’s assets are in generating revenue. It is computed by dividing net income by average total assets.
ttm (trailing twelve months)
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
Ret. on assets of companies in the Health Care sector on NASDAQ compared to AC Immune SA
What does AC Immune SA do?
ac immune is a clinical-stage swiss-based biopharmaceutical company, listed on nasdaq, which aims to become a global leader in precision medicine for neurodegenerative diseases. the company designs, discovers and develops therapeutic as well as diagnostic products intended to prevent and modify diseases caused by misfolding proteins. ac immune’s two proprietary technology platforms create antibodies, small molecules and vaccines designed to address a broad spectrum of neurodegenerative indications, such as alzheimer’s disease (ad). the company’s pipeline features nine therapeutic and three diagnostic product candidates – with five product candidates currently in clinical trials. the most advanced of these is crenezumab, a humanized anti-amyloid-β monoclonal igg4 antibody that targets monomeric and aggregated forms of amyloid-β, with highest affinity for neurotoxic oligomers. crenezumab is currently in two phase 3 clinical studies for ad, under a global program conducted by the collabor
Companies with ret. on assets similar to AC Immune SA
- Genetic Signatures has Ret. on assets of -31.96%
- Environmental Clean Technologies has Ret. on assets of -31.94%
- Dash Capital Corp has Ret. on assets of -31.93%
- Exore Resources has Ret. on assets of -31.93%
- Trafalgar Property plc has Ret. on assets of -31.91%
- Doumob has Ret. on assets of -31.89%
- AC Immune SA has Ret. on assets of -31.89%
- CFI-Compagnie Fonciere Internationale has Ret. on assets of -31.88%
- Small Pharma Inc has Ret. on assets of -31.86%
- Centaurus Metals has Ret. on assets of -31.86%
- Musee Grevin SA has Ret. on assets of -31.86%
- Creades AB has Ret. on assets of -31.85%
- MeiraGTx plc has Ret. on assets of -31.85%